EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Cobalt Single‐Atom Nanozyme for Enhanced Intestinal Radioprotection and Tumor Radiosensitization via Bidirectional ROS Modulation

Shengqi Yin, Junjie Li, Yishu Zou, Yang Liu, Yilin Zheng, Lu Yu iD, Wanying Zheng, Yajun Zou, Zehui Zhang, Tao Li, Peiqun Yin, Jianlin Zhang iD and 2 more

Advanced Science · 2026-10 · 13 (55)

DOI: 10.1002/advs.76491 ↗

At a glance

Journal article in Advanced Science, published online on 2026-07-07. Written by Shengqi Yin and 13 co-authors. Institution: Center of Radiation Oncology Department, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China. Major MEDLINE topics: Reactive Oxygen Species, Cobalt, Radiation-Protective Agents, Radiation-Sensitizing Agents. Cited 2 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Start-Up Grant from Anhui Medical University and University Natural Science Research of Anhui Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Herein, we develop an orally administered cobalt single‐atom nanozyme (Co‐SAN) featuring pH‐responsive, bifunctional catalytic activity to enable simultaneous intestinal radioprotection and tumor radiosensitization. In the alkaline intestinal microenvironment, Co‐SAN effectively scavenges radiation‐induced reactive oxygen species (ROS)‐as validated by flow cytometry, thereby mitigating radiation‐induced intestinal injury (RIII). Mechanistically, RNA‐seq analysis reveals that beyond direct ROS elimination, Co‐SAN downregulates the ROS‐mediated PI3K/AKT signaling pathway, significantly suppressing the formation of detrimental neutrophil extracellular traps (NETs). Furthermore, this highly biocompatible nanozyme maintains gut microbiota homeostasis and preserves intestinal barrier integrity. In contrast, within the mildly acidic tumor microenvironment (TME), Co‐SAN undergoes a catalytic switch to promote ROS generation and ameliorate hypoxia, potently augmenting radiotherapeutic efficacy. Collectively, this study presents a bifunctional single‐atom nanozyme that resolves the spatial contradiction between normal tissue protection and targeted tumor sensitization, offering a promising paradigm to substantially widen the therapeutic window of radiotherapy.

Subjects

MeSH terms (MEDLINE)

Reactive Oxygen SpeciesCobaltRadiation-Protective AgentsRadiation-Sensitizing AgentsIntestinesRadiation ToleranceAnimalsMiceTumor MicroenvironmentHumans

Author keywords

ROS modulationpH‐responsiveradioprotectionradiosensitizationsingle‐atom nanozyme

Substances

Reactive Oxygen SpeciesCobaltRadiation-Protective AgentsRadiation-Sensitizing Agents

Authors and institutions

  • Center of Radiation Oncology Department, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
  • Guangdong Province Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, P. R. China.
  • School of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei, P. R. China.
  • The First Clinical Medical College of Jinan University, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, P. R. China.
  • Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P. R. China.
  • Key Laboratory of Precision and Intelligent Chemistry, University of Science and Technology of China, Hefei, P. R. China.

ORCID profiles: Lu Yu, Jianlin Zhang, Yuen Wu

Funding

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Start-Up Grant from Anhui Medical University and University Natural Science Research of Anhui Province
  • Basic and Clinical Collaboration Enhancement Program Foundation of Anhui Medical University

Cite

APA

Yin, S., Li, J., Zou, Y., Liu, Y., Zheng, Y., Yu, L., Zheng, W., Zou, Y., Zhang, Z., Li, T., Yin, P., Zhang, J., Wu, Y., & Ding, Y. (2026). Cobalt Single‐Atom Nanozyme for Enhanced Intestinal Radioprotection and Tumor Radiosensitization via Bidirectional ROS Modulation. Advanced Science, 13(55). https://doi.org/10.1002/advs.76491

Vancouver

Yin S, Li J, Zou Y, Liu Y, Zheng Y, Yu L, et al. Cobalt Single‐Atom Nanozyme for Enhanced Intestinal Radioprotection and Tumor Radiosensitization via Bidirectional ROS Modulation. Advanced Science. 2026;13(55). doi:10.1002/advs.76491

BibTeX
@article{Yin2026,
  author = {Yin, Shengqi and Li, Junjie and Zou, Yishu and Liu, Yang and Zheng, Yilin and Yu, Lu and Zheng, Wanying and Zou, Yajun and Zhang, Zehui and Li, Tao and Yin, Peiqun and Zhang, Jianlin and Wu, Yuen and Ding, Yi},
  title = {Cobalt Single‐Atom Nanozyme for Enhanced Intestinal Radioprotection and Tumor Radiosensitization via Bidirectional ROS Modulation},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {55},
  doi = {10.1002/advs.76491}
}
Start for free →